Slowing progression of Alzheimer's disease by modulating the kynurenine pathway

Project: Research

Status	Finished
Effective start/end date	1/01/17 → 31/12/19

Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-β
Cespedes, M., Jacobs, K. R., Maruff, P., Rembach, A., Fowler, C. J., Trounson, B., Pertile, K. K., Rumble, R. L., Rainey-Smith, S. R., Rowe, C. C., Villemagne, V. L., Bourgeat, P., Lim, C. K., Chatterjee, P., Martins, R. N., Ittner, A., Masters, C. L., Doecke, J. D., Guillemin, G. J. & Lovejoy, D. B., Sept 2022, In: Neurobiology of Disease. 171, p. 1-9 9 p., 105783.
Research output: Contribution to journal › Article › peer-review

Open Access
File
20 Link opens in a new tab Citations (Scopus)

101 Downloads (Pure)
Potential mechanism of cellular uptake of the excitotoxin quinolinic acid in primary human neurons
Braidy, N., Alicajic, H., Pow, D., Smith, J., Jugder, B. E., Brew, B. J., Nicolazzo, J. A. & Guillemin, G. J., Jan 2021, In: Molecular Neurobiology. 58, 1, p. 34-54 21 p.
Research output: Contribution to journal › Article › peer-review
10 Link opens in a new tab Citations (Scopus)
Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer’s disease and relationship to amyloid-β and tau
Jacobs, K., Lim, C. K., Blennow, K., Zetterberg, H., Chatterjee, P., Martins, R. N., Brew, B., Guillemin, G. & Lovejoy, D., 1 Aug 2019, In: Neurobiology of Aging. 80, p. 11-20 10 p.
Research output: Contribution to journal › Article › peer-review
119 Link opens in a new tab Citations (Scopus)

Project Details